Helios Clinical Research is a clinical trial network that simplifies research and accelerates the availability of new therapies.

Helios Clinical Research

Helios Clinical Research | 3,147 followers on LinkedIn. Helios Clinical Research is a clinical site organization that partners with patients, physicians and biopharma sponsors. | Helios Clinical Research actively works with biopharma partners to accelerate the drug approval process. Its fully integrated clinical research network focuses on study startup, recruitment of and engagement with patients, and regulatory compliance management. Through the strategic navigation of these steps, Helios Clinical Research delivers valuable data to biopharma clients.

Chief Financial Officer and Chief Operating Officer at Helios

Natalie Gassen

Professor of Medicine - Endocrinology/Metabolism - UNC

G Stephen DeCherney, MD, MPH

Lauren Foreman

Sr. VP of Clinical Operations

Kim Kundert BSN

Excited to announce our event in San Diego on November 21st! 🎉 This is an informal Happy Hour/networking event, and Helios Clinical Research would love to host you! If you are interested in attending, please email bd@heliosclinical.com or reply to this post for more information. We look forward to connecting with an incredible group of leaders! We are partnering with Viedoc , Thorough Group , Capgemini , ClinAI and, GRINN . #HeliosClinicalResearch #SanDiego #TimeIsPrecious #Networking #Event #Pharma

As temperatures begin to drop and winter approaches, it’s a good time to think about your lung health. Pneumonia, a serious lung infection, can affect anyone, especially young children, the elderly, and those with weakened immune systems. 💉 It’s not too late to get your pneumonia vaccine! This simple step can protect you and your loved ones during cold and flu season. If you're eligible, talk to your healthcare provider to see if the vaccine is right for you. Let’s work together to spread awareness and help prevent pneumonia cases this season. Stay warm, stay healthy, and protect your lungs! #WorldPneumoniaDay #LungHealth #PneumoniaAwareness #VaccinesWork #HeliosCares #StayHealthy

Honoring Our Veterans Today and Every Day This Veterans Day, we at Helios Clinical Research want to extend our deepest gratitude to all veterans for their courage, resilience, and unwavering dedication. Your service has paved the way for the freedoms we enjoy, and your sacrifices inspire us every day. Today, let’s honor our veterans with respect and appreciation—may we never take for granted the freedoms they’ve fought to protect. Thank you for your service. 💙❤️ #VeteransDay #HeliosClinical #HonoringOurHeroes #Veterans #ThankYou #ResearchForHealth

License to Build... Business! 🕶️ Lauren Foreman and Wes Linder brought their best Bond faces to the Obesity Society meeting this week. Neither shaken, nor stirred, but ready to tackle obesity research like pros! Have a question about conducting a trial for your study? Call the pros. 📧 BD@heliosclinical.com 📲 855-2-HELIOS #HeliosClinical #ObesitySociety #WeHaveYourPatients

Celebrating Our Team's Work Anniversaries! 🎉 We are thrilled to recognize and celebrate the work anniversaries of some amazing members of our team this month. Your dedication, hard work, and passion have been instrumental in our success, and we're grateful to have you with us. Thank you for your unwavering commitment and the positive impact you've made on our company! #WorkAnniversary #TeamAppreciation #Grateful

We're #hiring a new Clinical Research Coordinator II in Phoenix, Arizona. Apply today or share this post with your network.

LinkedIn network! Urgent hire in Phoenix, AZ! Join our amazing and growing team! Feel free to message me directly. We are ready to interview and get the ball rolling! #clinicalresearch #hiring #growth #CRC Helios Clinical Research

Janine Stock, SHRM-CP

Have a safe and fun #Halloween everyone! #HappyHalloween

Helios is excited to share we will be attending #ObesityWeek in lovely San Antonio TX! (Where the weather will still be in the 80's!) 😎 We are eager to engage with colleagues and share how we can facilitate the groundbreaking research that’s transforming how we understand and treat obesity. 👀 Look for ➡ Lauren Foreman or Wes Linder to discuss how we can help shape the future of obesity treatment through research. 📧 Email us for our latest obesity study metrics: BD@Heliosclincial.com

Metric
Company Name	Helios Clinical Research
Symbol
MSH ID	COM:HELIOSCLINICAL
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Clinical Research
Country	US
Stage
Employee Count
Website	heliosclinical.com
LinkedIn	helios-clinical-research
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	48
Web Traffic Growth	-0.62
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

HELI

COM:HELIOSCLINICAL

Helios Clinical Research

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue